RapidAI Revenue and Competitors
Estimated Revenue & Valuation
- RapidAI's estimated annual revenue is currently $15M per year.
- RapidAI's estimated revenue per employee is $63,559
- RapidAI's total funding is $100M.
Employee Data
- RapidAI has 236 Employees.
- RapidAI grew their employee count by 1% last year.
RapidAI's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and Technical Lead | Reveal Email/Phone |
2 | SVP Regulatory and Clinical | Reveal Email/Phone |
3 | VP International Sales & Ops | Reveal Email/Phone |
4 | VP Clinical Affairs | Reveal Email/Phone |
5 | VP Engineering | Reveal Email/Phone |
6 | Director, FP&A | Reveal Email/Phone |
7 | Revenue Manager and Financial Analyst | Reveal Email/Phone |
8 | Human Resources Administrator | Reveal Email/Phone |
9 | Clinical Workflow Consultant | Reveal Email/Phone |
10 | Chairman, Co-Founder and Scientific Lead | Reveal Email/Phone |
RapidAI Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.5M | 99 | -1% | $38.2M | N/A |
#2 | $35M | 209 | 0% | $383.7M | N/A |
#3 | $15M | 236 | 1% | $100M | N/A |
What Is RapidAI?
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,500 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH and Rapid ASPECTS. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke patients using clinically proven, data-driven technology. With our validated, trusted platform, developed by stroke experts, clinicians worldwide are improving patient care and outcomes every day. The Rapid platform has been shown to aid in patient selection in both early and late-window clinical stroke trials. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, the results of these trials led to new American Heart Association and American Stroke Association treatment guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit RapidAI.com.
keywords:N/A
$100M
Total Funding
236
Number of Employees
$15M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RapidAI News
--(BUSINESS WIRE)--RapidAI, the global leader in neurovascular and vascular imaging driving the next evolution of clinical decision making and...
SAN MATEO, Calif., June 8, 2021 /PRNewswire/ -- RapidAI, the leader in clinical learning and development for stroke, aneurysm, and other cerebrovascular and vascular conditions, today announced the availability of Continuing Education (CE) and Continuing Medical Education (CME) credits for hea ...
RapidAI, a San Mateo, Calif.-based leader in advanced imaging for stroke, raised $25m in Series B funding. The round was by Lennertz & Co. Building. The company intends to use the funds to advance the Rapid® platform and its clinical products. Founded in 2011 and led by Don Listwin, CEO, Rapi ...
RapidAI (formerly iSchemaView), a startup developing a portfolio of stroke imaging and assessment products, today closed a $25 million round. The company says the funds will be put toward strategic growth initiatives around the world. “Given our growth and profitability, we intend to use the st ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $37.8M | 237 | 14% | N/A |
#2 | $43.3M | 260 | 0% | $108.7M |
#3 | $750M | 274 | 5% | N/A |
#4 | $0.4M | 275 | 10% | $236.7M |
#5 | $15M | 280 | 21% | N/A |